WHO may take a call on Covaxin today

The experts will also discuss the clinical data on Covaxin from phase 1, 2, 3 trials and post marketing studies on safety, immunogenicity, efficacy and effectiveness, besides update on global, regional and country level plans for vaccine safety monitoring, the SAGE agenda said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ixxzss
via IFTTT